Atrial fibrillation in hypertrophic cardiomyopathy-A contemporary mini-review

被引：10

作者：

Dragasis, Stylianos ^{[1
]}

Vlachos, Konstantinos ^{[1
]}

Kariki, Ourania ^{[1
]}

Koskina, Stavroula ^{[1
]}

Zygouri, Andromahi ^{[1
]}

Patsiotis, Ilias G. ^{[2
]}

Anastasakis, Aris ^{[1
]}

Athanasopoulos, George ^{[1
]}

Ritsatos, Konstantinos ^{[1
]}

Letsas, Konstantinos ^{[1
]}

Efremidis, Michael ^{[1
]}

机构：

[1] Onassis Cardiac Surg Canter, Leof Andrea Siggrou 356, Athens 17674, Greece

[2] Gen State Hosp Nikaia St Panteleimon, Nikaia, Greece

来源：

HELLENIC JOURNAL OF CARDIOLOGY | 2022年 / 67卷

关键词：

Atrial fibrillation; Hypertrophic cardiomyopathy; Arterial thromboembolism; CLINICAL PROFILE; SURGICAL ABLATION; OUTCOMES; IMPACT; PREDICTORS; MANAGEMENT; DIAGNOSIS; FIBROSIS; CATHETER; STROKE;

D O I：

10.1016/j.hjc.2022.05.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) represents the most common genetically inherited cardiovascular disorder and a leading cause of heart failure and sudden cardiac death. Atrial fibrillation (AF) is the most common arrhythmia encountered in HCM patients, primarily due to the process of left atrium dilatation and remodeling. Its presence typically leads to progressive functional decline, increased frequency of heart failure hospitalizations, and increased thromboembolic risk. In this mini-review, we summarize the contemporary data on AF pathophysiology, risk factors, and management in HCM patients suffering from AF.(c) 2022 Hellenic Society of Cardiology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页码：66 / 72

页数：7

共 50 条

[41] Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study
Jung, Hyunjean
Yang, Pil-Sung
Sung, Jung-Hoon
Jang, Eunsun
Yu, Hee Tae
Kim, Tae-Hoon
Uhm, Jae-Sun
Kim, Jong-Youn
Pak, Hui-Nam
Lee, Moon-Hyoung
Lip, Gregory Y. H.
Joung, Boyoung
THROMBOSIS AND HAEMOSTASIS, 2019, 119 (02) : 285 - 293
[42] Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long Term Outcome
Dinshaw, Leon
Muenkler, Paula
Schaeffer, Benjamin
Klatt, Niklas
Jungen, Christiane
Dickow, Jannis
Tamenang, Annika
Schleberger, Ruben
Pecha, Simon
Pinnschmidt, Hans
Patten, Monica
Reichenspurner, Hermann
Willems, Stephan
Meyer, Christian
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (03): : 1 - 13
[43] Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review
Hakeem S. K. Ha
Nelson Wang
Sophia Wong
Steven Phan
Jace Liao
Narendra Kumar
Pierre Qian
Tristan D. Yan
Kevin Phan
Journal of Interventional Cardiac Electrophysiology, 2015, 44 : 161 - 170
[44] Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic disease
Efremidis, Michael
Bazoukis, George
Vlachos, Konstantinos
Prappa, Efstathia
Anastasakis, Aris
Megarisiotou, Athanasia
Dragasis, Stelios
Asvestas, Dimitrios
Mililis, Panagiotis
Saplaouras, Athanasios
Efremidis, Theodoros
Batsouli, Athena
Zimpounoumi, Natalia
Valkanas, Kosmas
Sideris, Antonios
Letsas, Konstantinos P.
JOURNAL OF ELECTROCARDIOLOGY, 2021, 69 : 87 - 92
[45] Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis
Zhou, Yunguo
He, Wenfeng
Zhou, Yue
Zhu, Wengen
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (02) : 311 - 317
[46] Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality
Zegkos, Thomas
Efthimiadis, Georgios K.
Parcharidou, Despoina G.
Gossios, Thomas D.
Giannakoulas, Georgios
Ntelios, Dimitris
Ziakas, Antonis
Paraskevaidis, Stelios
Karvounis, Haralambos I.
HELLENIC JOURNAL OF CARDIOLOGY, 2017, 58 (05) : 331 - 339
[47] Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study
Hsu, Jung-Chi
Huang, Ya-Ting
Lin, Lian-Yu
AGING-US, 2020, 12 (23): : 24219 - 24227
[48] Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
Boll, Griffin
Rowin, Ethan J.
Maron, Barry J.
Wang, Wendy
Rastegar, Hassan
Maron, Martin S.
AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (01) : 120 - 126
[49] Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy
Olivotto I.
Maron B.J.
Cecchi F.
Current Cardiology Reports, 2001, 3 (2) : 141 - 146
[50] Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?
Frontera, Antonio
Wilson, D. G.
Sekhon, H.
Duncan, E. R.
Thomas, G.
CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (10) : 799 - 802

← 1 2 3 4 5 →